These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. Eberhart CG; Kratz J; Wang Y; Summers K; Stearns D; Cohen K; Dang CV; Burger PC J Neuropathol Exp Neurol; 2004 May; 63(5):441-9. PubMed ID: 15198123 [TBL] [Abstract][Full Text] [Related]
12. Cerebellum development and medulloblastoma. Roussel MF; Hatten ME Curr Top Dev Biol; 2011; 94():235-82. PubMed ID: 21295689 [TBL] [Abstract][Full Text] [Related]
13. Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2. Shakhova O; Leung C; van Montfort E; Berns A; Marino S Cancer Res; 2006 May; 66(10):5190-200. PubMed ID: 16707443 [TBL] [Abstract][Full Text] [Related]
18. FOXG1 expression shows correlation with neuronal differentiation in cerebellar development, aggressive phenotype in medulloblastomas, and survival in a xenograft model of medulloblastoma. Adesina AM; Veo BL; Courteau G; Mehta V; Wu X; Pang K; Liu Z; Li XN; Peters L Hum Pathol; 2015 Dec; 46(12):1859-71. PubMed ID: 26433703 [TBL] [Abstract][Full Text] [Related]
19. BarTeL, a Genetically Versatile, Bioluminescent and Granule Neuron Precursor-Targeted Mouse Model for Medulloblastoma. Shackleford GM; Shi XH; Swanson KS; Mahdi MY; Gonzalez-Gomez I; Asgharzadeh S; D'Apuzzo M; Erdreich-Epstein A; Moats RA PLoS One; 2016; 11(6):e0156907. PubMed ID: 27310018 [TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin signaling inhibits the Shh pathway and impairs tumor growth in Shh-dependent medulloblastoma. Pöschl J; Bartels M; Ohli J; Bianchi E; Kuteykin-Teplyakov K; Grammel D; Ahlfeld J; Schüller U Acta Neuropathol; 2014 Apr; 127(4):605-7. PubMed ID: 24531885 [No Abstract] [Full Text] [Related] [Next] [New Search]